Corpay Other Non-Current Liabilities decreased by 0.5% to $609.26M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.8%, from $469.52M to $609.26M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 17.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $259.06M | $258.70M | $221.39M | $220.05M | $256.67M | $304.24M | $254.01M | $801.97M | $801.07M | $829.59M | $301.75M | $261.06M | $315.55M | $440.59M | $437.88M | $469.52M | $579.96M | $519.80M | $612.28M | $609.26M |
| QoQ Change | — | -0.1% | -14.4% | -0.6% | +16.6% | +18.5% | -16.5% | +215.7% | -0.1% | +3.6% | -63.6% | -13.5% | +20.9% | +39.6% | -0.6% | +7.2% | +23.5% | -10.4% | +17.8% | -0.5% |
| YoY Change | — | — | — | — | -0.9% | +17.6% | +14.7% | +264.4% | +212.1% | +172.7% | +18.8% | -67.4% | -60.6% | -46.9% | +45.1% | +79.9% | +83.8% | +18.0% | +39.8% | +29.8% |